Orforglipron
ATTAIN-OA PAIN
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Orforglipron (GZT1) | n/r | n/r | n/r | n/r | n/r |
| Placebo (GZT1) | n/r | n/r | n/r | n/r | n/r |
| Orforglipron (GZT2) | n/r | n/r | n/r | n/r | n/r |
| Placebo (GZT2) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.